Suppr超能文献

从系统性红斑狼疮患者血清中分离出的一种因子F - 42对经典途径C3转化酶C42的稳定作用。

Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.

作者信息

Daha M R, Hazevoet H M, Vanes L A, Cats A

出版信息

Immunology. 1980 Jul;40(3):417-24.

Abstract

Sera from sixteen patients with SLE were investigated for the presence of a factor which would conserve convertase activity on preformed EAClgp 4hu2hu for 30 min at 30 degrees in EDTA. Although such a factor could not be detected readily in the sera, chromatography on DE-52 cellulose yielded fractions appearing as three peaks in one patient and as two peaks in a second patient. These peaks were capable of conserving C42 activity and were designated as F-42. Purification of F-42 from the second peak eluting between 4 and 7 mS on DE-52 was obtained by SP-C50, S-300 and QAE-A50 chromatography. F-42 exhibited charge heterogeneity upon SP-C50 chromatography. On polyacrylamide gel electrophoresis the final material migrated as one band, which coincided with the position of F-42 activity upon eluation from a parallel gel. F-42 had an apparent molecular weight of 150,000 and reacted with anti-IgG in Ouchterlony analysis. Sepharose-bound anti-IgG was capable of neutralizing F-42 activity. The purified material was shown to prolong the half-life (T 1/2) of performed cell-bound C42 in GVB-EDTA at 30 degrees from 5 to 80 min.

摘要

对16例系统性红斑狼疮(SLE)患者的血清进行检测,以寻找一种能在30℃的乙二胺四乙酸(EDTA)中,使预先形成的EAClgp 4hu2hu上的转化酶活性在30分钟内得以保留的因子。尽管在这些血清中未能轻易检测到这样一种因子,但在DE-52纤维素上进行层析时,在一名患者中得到的组分呈现为三个峰,在另一名患者中呈现为两个峰。这些峰能够保留C42活性,被命名为F-42。通过SP-C50、S-300和QAE-A50层析从DE-52上洗脱的第二个峰中纯化F-42。F-42在SP-C50层析时表现出电荷不均一性。在聚丙烯酰胺凝胶电泳中,最终产物迁移为一条带,这与从平行凝胶洗脱时F-42活性的位置一致。F-42的表观分子量为150,000,在双向免疫扩散分析中与抗IgG发生反应。琼脂糖结合的抗IgG能够中和F-42的活性。纯化后的物质显示,在30℃的GVB-EDTA中,能使预先形成的细胞结合C42的半衰期(T 1/2)从5分钟延长至80分钟。

相似文献

引用本文的文献

1
Acquired drivers of C3 glomerulopathy.C3肾小球病的后天性驱动因素。
Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar.
2
Challenges in diagnostic testing of nephritic factors.肾病因子诊断检测的挑战。
Front Immunol. 2022 Nov 14;13:1036136. doi: 10.3389/fimmu.2022.1036136. eCollection 2022.
7
Complement components and their autoantibodies.补体成分及其自身抗体。
Mol Biotechnol. 2003 Mar;23(3):259-70. doi: 10.1385/MB:23:3:259.
10
Complement deficiency and immune complex disease.补体缺陷与免疫复合物疾病
Springer Semin Immunopathol. 1994;15(4):397-416. doi: 10.1007/BF01837367.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验